In the first three months of the new financial year, the company recorded revenues of EUR 219.0m (previous year: EUR 210.3m) and EBIT of EUR 31.2m (previous year: EUR 28.3m). The EBIT margin improved ...

A week ago, Carl Zeiss Meditec AG (ETR:AFX) came out with a strong set of interim numbers that could potentially lead to a re-rate of the stock. The company beat forecasts, with revenue of €1.1b, some ...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be intrigued to know that Carl Zeiss Meditec AG (ETR:AFX) is about to go ex-dividend ...

Find insight on Straumann, Novo Nordisk, Novartis and more in the latest Market Talks covering the Health Care sector. Key Insights The considerable ownership by private companies in Carl Zeiss ...

Acquisition will extend the company's leadership in ophthalmic medical devices market and expands its position in the vitreo-retinal surgery segment D.O.R.C., a leading player in the retinal surgical ...

ZEISS Medical Technology announced today that the ILM staining dye ILM-Blue® from DORC (Dutch Ophthalmic Research Center (International) B.V.) has received National Medical Products Administration ...

Around 41 percent of Carl Zeiss Meditec AG shares are in free float. The remaining approximately 59 percent are held by Carl Zeiss AG, one of the world's leading companies in the optical and ...

When it comes to camera optics and lenses, one of the biggest names in the industry is Carl Zeiss. The company has announced that it will be entering into the micro four thirds market with Olympus.

As of 9:50:49 am GMT+1. Market open. Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be... Carl Zeiss Meditec AG ( ETR:AFX ) has ...

D.O.R.C., a leading player in the retinal surgical devices market, will be a key contributor to ZEISS Medical Technology's long-term strategy and success going forward. With the acquisition, ZEISS ...